167 related articles for article (PubMed ID: 24626470)
1. Performance related factors are the main determinants of the von Willebrand factor response to exhaustive physical exercise.
van Loon JE; Sonneveld MA; Praet SF; de Maat MP; Leebeek FW
PLoS One; 2014; 9(3):e91687. PubMed ID: 24626470
[TBL] [Abstract][Full Text] [Related]
2. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
[TBL] [Abstract][Full Text] [Related]
3. Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.
van Loon JE; Leebeek FW; Deckers JW; Dippel DW; Poldermans D; Strachan DP; Tang W; O'Donnell CJ; Smith NL; de Maat MP
Circ Cardiovasc Genet; 2010 Dec; 3(6):507-12. PubMed ID: 21156930
[TBL] [Abstract][Full Text] [Related]
4. Interaction networks of Weibel-Palade body regulators syntaxin-3 and syntaxin binding protein 5 in endothelial cells.
Schillemans M; Karampini E; Hoogendijk AJ; Wahedi M; van Alphen FPJ; van den Biggelaar M; Voorberg J; Bierings R
J Proteomics; 2019 Aug; 205():103417. PubMed ID: 31201948
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
6. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis.
Matsuyama T; Uemura M; Ishikawa M; Matsumoto M; Ishizashi H; Kato S; Morioka C; Fujimoto M; Kojima H; Yoshiji H; Takimura C; Fujimura Y; Fukui H
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S27-35. PubMed ID: 17331163
[TBL] [Abstract][Full Text] [Related]
7. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
8. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
[TBL] [Abstract][Full Text] [Related]
10. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.
Zhu Q; Yamakuchi M; Ture S; de la Luz Garcia-Hernandez M; Ko KA; Modjeski KL; LoMonaco MB; Johnson AD; O'Donnell CJ; Takai Y; Morrell CN; Lowenstein CJ
J Clin Invest; 2014 Oct; 124(10):4503-16. PubMed ID: 25244095
[TBL] [Abstract][Full Text] [Related]
11. Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.
Horii M; Uemura S; Uemura M; Matsumoto M; Ishizashi H; Imagawa K; Iwama H; Takeda Y; Kawata H; Nakajima T; Fujimura Y; Saito Y
Heart Vessels; 2008 Sep; 23(5):301-7. PubMed ID: 18810578
[TBL] [Abstract][Full Text] [Related]
12. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
13. High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability.
Bongers TN; de Maat MP; van Goor ML; Bhagwanbali V; van Vliet HH; Gómez García EB; Dippel DW; Leebeek FW
Stroke; 2006 Nov; 37(11):2672-7. PubMed ID: 16990571
[TBL] [Abstract][Full Text] [Related]
14. Reduced ADAMTS13 in children with severe meningococcal sepsis is associated with severity and outcome.
Bongers TN; Emonts M; de Maat MP; de Groot R; Lisman T; Hazelzet JA; Leebeek FW
Thromb Haemost; 2010 Jun; 103(6):1181-7. PubMed ID: 20390223
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide association studies identify genetic loci for low von Willebrand factor levels.
van Loon J; Dehghan A; Weihong T; Trompet S; McArdle WL; Asselbergs FW; Chen MH; Lopez LM; Huffman JE; Leebeek FW; Basu S; Stott DJ; Rumley A; Gansevoort RT; Davies G; Wilson JJ; Witteman JC; Cao X; de Craen AJ; Bakker SJ; Psaty BM; Starr JM; Hofman A; Wouter Jukema J; Deary IJ; Hayward C; van der Harst P; Lowe GD; Folsom AR; Strachan DP; Smith N; de Maat MP; O'Donnell C
Eur J Hum Genet; 2016 Jul; 24(7):1035-40. PubMed ID: 26486471
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and mutations in vWF and ADAMTS13 genes and their correlation with plasma levels of FVIII and vWF in patients with deep venous thrombosis.
Bittar LF; de Paula EV; Mello TB; Siqueira LH; Orsi FL; Annichino-Bizzacchi JM
Clin Appl Thromb Hemost; 2011 Oct; 17(5):514-8. PubMed ID: 20682599
[TBL] [Abstract][Full Text] [Related]
17. Left atrial blood stasis and Von Willebrand factor-ADAMTS13 homeostasis in atrial fibrillation.
Ammash N; Konik EA; McBane RD; Chen D; Tange JI; Grill DE; Herges RM; McLeod TG; Friedman PA; Wysokinski WE
Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2760-6. PubMed ID: 21852562
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia.
Molvarec A; Rigó J; Bõze T; Derzsy Z; Cervenak L; Makó V; Gombos T; Udvardy ML; Hársfalvi J; Prohászka Z
Thromb Haemost; 2009 Feb; 101(2):305-11. PubMed ID: 19190814
[TBL] [Abstract][Full Text] [Related]
19. Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis.
O'Donnell JS; McKinnon TA; Crawley JT; Lane DA; Laffan MA
Blood; 2005 Sep; 106(6):1988-91. PubMed ID: 15886321
[TBL] [Abstract][Full Text] [Related]
20. Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty.
Liu L; Ling J; Ma Z; Yuan Q; Pan J; Yang H
Mol Med Rep; 2015 Apr; 11(4):3015-20. PubMed ID: 25482054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
